http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007248630-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c38c7c5ba7d06ba5187ddf5f2df1dbb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
filingDate 2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec9140555b5ee1e5b0b7aa4a76d239a8
publicationDate 2007-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2007248630-A1
titleOfInvention Pharmaceutical formulations for iontophoretic methotrexate delivery
abstract Pharmaceutical formulations suitable for iontophoresis that provide enhanced iontophoretic delivery of methotrexate to at least one target tissue are described and methods for administering methotrexate via iontophoresis.
priorityDate 2006-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4329332-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4043759-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004131646-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005004509-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005153969-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5068227-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004241162-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003149393-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5624415-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5674521-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6477410-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5516808-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4489055-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450984220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5102882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449188861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57448911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71308275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507158

Total number of triples: 50.